MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer

Introduction: Early identification of chemoresistance in patients with ovarian cancer is of utmost importance in order to provide them with the most appropriate therapy. Recently, we described the expression of MyD88 in ovarian cancer cells that were resistant to the cytotoxic agent paclitaxel. In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Silasi, Dan-Arin, Alvero, Ayesha B., Illuzzi, Jessica, Kelly, Michael, Chen, Rui, Fu, Han-Hsuan, Schwartz, Peter, Rutherford, Thomas, Azodi, Masoud, Mor, Gil
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 2007
Materias:
Novel Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994803/
https://www.ncbi.nlm.nih.gov/pubmed/17940625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994803/
https://www.ncbi.nlm.nih.gov/pubmed/17940625

Ejemplares similares